BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 74.01%-27.04M | ---- | -89.53%-104.04M | ---- | -129.13%-54.89M | ---- | 16.85%-23.96M | ---- | -278.26%-28.81M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -50.00%-3K | ---- | 71.43%-2K | ---- | 63.16%-7K | ---- | -18.75%-19K | ---- | -1,500.00%-16K |
Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | 28.83%8.85M | ---- | 129.67%6.87M | ---- | 7.17%2.99M |
Impairment and provisions: | ---- | -89.24%8.81M | ---- | 54.36%81.8M | ---- | 645.11%52.99M | ---- | -38.25%7.11M | ---- | 62.84%11.52M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | 41.75%75.12M | ---- | 992.84%52.99M | ---- | --4.85M | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 31.79%8.81M | ---- | --6.68M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.35%2.26M | ---- | 62.84%11.52M |
Revaluation surplus: | ---- | -108.66%-414K | ---- | 166.45%4.78M | ---- | -1,162.46%-7.2M | ---- | -42.50%-570K | ---- | ---400K |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | 43.86%-320K | ---- | -42.50%-570K | ---- | ---400K |
-Other fair value changes | ---- | -108.66%-414K | ---- | 169.55%4.78M | ---- | ---6.88M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---3.11M | ---- | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---3.11M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -76.99%1.89M | ---- | -1.85%8.21M | ---- | 109.31%8.36M | ---- | -1.79%3.99M | ---- | 37.72%4.07M |
Financial expense | ---- | -34.37%3.07M | ---- | --4.68M | ---- | ---- | ---- | ---- | ---- | ---- |
Special items | ---- | ---- | ---- | 255.62%1.27M | ---- | -58.41%356K | ---- | -70.00%856K | ---- | -51.34%2.85M |
Operating profit before the change of operating capital | ---- | -313.97%-13.69M | ---- | -161.74%-3.31M | ---- | 193.70%5.36M | ---- | 26.72%-5.72M | ---- | -170.52%-7.8M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 77.38%-1.2M | ---- | -15.85%-5.31M | ---- | -211.33%-4.58M | ---- | -79.04%4.11M | ---- | 293.97%19.62M |
Accounts receivable (increase)decrease | ---- | -1,088.84%-18.79M | ---- | -57.24%1.9M | ---- | -68.32%4.44M | ---- | 788.09%14.02M | ---- | -79.13%1.58M |
Accounts payable increase (decrease) | ---- | 141.93%22.89M | ---- | 330.06%9.46M | ---- | -148.47%-4.11M | ---- | 1,682.35%8.48M | ---- | 102.82%476K |
prepayments (increase)decrease | ---- | -88.16%4M | ---- | 231.65%33.77M | ---- | -189.09%-25.65M | ---- | 215.74%28.79M | ---- | 13.59%-24.88M |
Cash from business operations | ---- | -118.60%-6.79M | ---- | 248.79%36.52M | ---- | -149.39%-24.54M | ---- | 551.91%49.7M | ---- | 70.42%-11M |
Interest received - operating | ---- | 50.00%3K | ---- | -71.43%2K | ---- | --7K | ---- | ---- | ---- | ---- |
Special items of business | -231.55%-14.41M | ---- | 50.63%-4.35M | ---- | 38.88%-8.8M | ---- | -1,698.56%-14.4M | ---- | 123.03%901K | ---- |
Net cash from operations | -231.55%-14.41M | -118.59%-6.79M | 50.63%-4.35M | 248.84%36.52M | 38.88%-8.8M | -149.37%-24.54M | -1,698.56%-14.4M | 551.91%49.7M | 123.03%901K | 70.60%-11M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 18.75%19K | ---- | 1,500.00%16K |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 134.54%1.1M |
Sale of fixed assets | ---- | --593K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | ---- | 93.90%-509K | ---- | 22.33%-8.34M | ---- | 90.98%-10.74M | ---- | -13,349.27%-119.03M | ---- | -54.72%-885K |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---15.52M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | 0.20%-1.99M | ---- | 67.44%-1.99M | ---- | ---6.11M | ---- | ---- | ---- | ---- |
Other items in the investment business | --3.46M | ---- | ---- | ---- | 727.47%7.56M | ---- | -153.20%-1.21M | ---- | 368.68%2.27M | ---- |
Net cash from investment operations | --3.46M | 81.58%-1.9M | ---- | 68.08%-10.33M | 727.47%7.56M | 72.80%-32.37M | -153.20%-1.21M | -51,618.18%-119.01M | 368.68%2.27M | 106.15%231K |
Net cash before financing | -152.05%-10.95M | -133.19%-8.69M | -249.92%-4.35M | 146.02%26.19M | 92.04%-1.24M | 17.90%-56.91M | -592.99%-15.61M | -543.80%-69.31M | 166.58%3.17M | 73.85%-10.77M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 35.71%38M | ---- | -60.00%28M | ---- | -46.37%70M | ---- | 146.75%130.53M | ---- | 32.25%52.9M |
Refund | ---- | 35.26%-28M | ---- | -25.25%-43.25M | ---- | 34.72%-34.53M | ---- | -32.25%-52.9M | ---- | -2.56%-40M |
Issuing shares | ---- | ---- | ---- | 99.56%23.1M | ---- | 51.44%11.57M | ---- | --7.64M | ---- | ---- |
Interest paid - financing | ---- | 34.37%-3.07M | ---- | 34.55%-4.68M | ---- | -4.15%-7.15M | ---- | -129.67%-6.87M | ---- | -7.17%-2.99M |
Pledged bank deposit (increase) decrease | ---- | 83.23%-855K | ---- | -201.96%-5.1M | ---- | 368.67%5M | ---- | ---1.86M | ---- | ---- |
Other items of the financing business | -116.58%-1.66M | ---- | ---766K | ---- | ---- | ---- | 603.60%9.23M | ---- | -121.18%-1.83M | ---- |
Net cash from financing operations | -116.58%-1.66M | 125.67%2.44M | ---766K | -124.23%-9.52M | ---- | -58.64%39.28M | 603.60%9.23M | 858.32%94.97M | -121.18%-1.83M | 653.63%9.91M |
Effect of rate | 282.61%264K | 1,052.44%781K | --69K | -107.47%-82K | ---- | 194.90%1.1M | -138.27%-124K | -272.28%-1.16M | 172.27%324K | -48.23%671K |
Net Cash | -146.73%-12.61M | -137.48%-6.25M | -311.59%-5.11M | 194.54%16.67M | 80.54%-1.24M | -168.72%-17.63M | -578.41%-6.38M | 3,097.55%25.66M | -65.73%1.33M | 98.01%-856K |
Begining period cash | -34.18%20.35M | 179.75%25.82M | 234.99%30.91M | -64.18%9.23M | -64.18%9.23M | 1,944.68%25.76M | 1,944.68%25.76M | -12.80%1.26M | -12.80%1.26M | -96.65%1.45M |
Cash at the end | -69.08%8M | -21.18%20.35M | 223.94%25.87M | 179.75%25.82M | -58.53%7.99M | -64.18%9.23M | 559.94%19.26M | 1,944.68%25.76M | -46.53%2.92M | -12.80%1.26M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | China Credit Letter (Hong Kong) Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.